Mode of peroxisome proliferator-activated receptor γ activation by luteolin - Wikidata - wikimedia - TriplyDB

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

http://www.wikidata.org/entity/Q27677850

about

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer Identification of a new hormone-binding site on the surface of thyroid hormone receptor Identification of PPARgamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.Peroxisome proliferator-activated receptors for hypertension.Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family.Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4α Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex.Flavonoids as dietary regulators of nuclear receptor activity Structural dataset for the PPARγ V290M mutant.Structure-Activity Relationship of 2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted Antidiabetics.The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.Main constituents of polyphenol complex from seagrasses of the genus Zostera, their antidiabetic properties and mechanisms of action.Hesperetin glucuronides induce adipocyte differentiation via activation and expression of peroxisome proliferator-activated receptor-γ.Chrysanthemum promotes adipocyte differentiation, adiponectin secretion and glucose uptake.A structural perspective on nuclear receptors as targets of environmental compounds.Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes.The small molecule luteolin inhibits N-acetyl-α-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein.Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice.SAR and Computer-Aided Drug Design Approaches in the Discovery of Peroxisome Proliferator-Activated ReceptorγActivators: A Perspective

P2860

Q24561401-A635D92D-62B5-4433-AA26-A59EEA5683A6 Q26747523-5DC11FCD-6C42-4891-AD6B-2EF9BC7671D6 Q26829126-4B41872A-1751-4611-91ED-E302269293F5 Q27689142-45DC4823-E312-4B6D-8A4E-9B85F0817441 Q28486003-730D6061-9DED-4D83-B836-2D1075E05E5C Q28552475-AA9A2D39-4D32-40CD-B72F-CE75D78A32D3 Q28818450-2A938E05-CC41-4F8B-9558-6AAFE1663244 Q33823673-B722827F-402F-4A13-92BA-D06864ABFC90 Q34179017-8BB8C91B-BA40-4B44-BF1E-7ADC1528003A Q34511474-C5A4EABB-767A-4914-9460-4A6FDB81DE88 Q35050607-C4108940-8563-4298-AB10-294A86C967C0 Q35576545-6203E06A-C5CA-42CB-8FEB-FF10FFCF076F Q36092936-C96AE8BC-66CE-42D5-A8F5-A120FD6AE03A Q36124999-992B95A0-2E6B-4981-AAF1-2BDFFF3456BF Q36517153-0482821E-FA32-40B7-9A77-59ED7072DE60 Q37193003-6AD12587-B21D-4900-BF0F-3093D4F44D93 Q37338524-896F7D50-BE38-40BE-90C5-9D43AAC888D8 Q38431378-24A872CC-2B91-4713-9F12-9A7ABCF2D0F0 Q38432731-71FAE0B7-F538-40D0-A4B0-145C33F9A008 Q39341939-D31EA906-3538-48B4-9983-DC00EDDA5114 Q42799442-9CF5AE35-8E9F-418C-8FFB-3018BCA31A12 Q42829342-A4AE0B47-AFD9-4B35-8AD8-D265AEDC32A8 Q43249416-B0C56155-B9B2-40BE-86D4-A0A01A8B9194 Q47111177-C00898A0-AC65-41FB-8632-F9DDAE267952 Q47613542-F04B96D7-0760-4FFC-A645-E51C63BF1C93 Q53589878-AF05EA75-C1FA-4E1A-96AA-C1EC4D59C557 Q58919671-190232BC-F3DE-4B82-B24F-7BE2B94FCE44

P2860

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

http://www.wikidata.org/entity/Q27677850

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@ast

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@en

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@nl

type

label

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@ast

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@en

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@nl

prefLabel

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@ast

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@en

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@nl

P1433

Q27677850-FB316CC9-C8C2-4BEE-B3D4-AA30435F5F94

P1476

Q27677850-187F60BC-78EB-4288-8D30-69E849598658

P2093

Q27677850-2353017B-E8F5-4442-9ED3-A4BCFB8D304E

Q27677850-274C0E34-18D7-4B16-9006-7C10C6ABB524

Q27677850-2861A15C-BE6D-4B6A-A032-C219E9410662

Q27677850-335485D3-8553-4F86-9D0E-1F68FFA9802C

Q27677850-4EE2F39D-AFCB-4A22-8EFC-FA99027CB361

Q27677850-65E72529-FF8E-4435-953E-799D7499E841

Q27677850-6E50EB20-7E9B-4D08-BE08-2D2E03FC8E64

Q27677850-7B253619-BA64-4EE9-B38A-CDB3E05BD582

Q27677850-8B511394-C8CC-4909-A7C2-EAF40CF09E41

Q27677850-C173A77F-E7EB-4BC5-ADE6-13C1CEF5CE98

P304

Q27677850-F22513D8-1B94-472D-868C-52134EFAAF76

P31

Q27677850-F1A3D69C-CE08-4F33-935E-A6C50621C19E

P3181

Q27677850-FF6B6DF8-817C-4CF6-A22E-3B236058B5A5

P356

Q27677850-2E403A2F-73E4-4B53-AD78-85F032A735E2

P433

Q27677850-10BF9748-42D5-4BCC-8320-B735B804B63E

P478

Q27677850-58DDAA66-14E1-4E2A-9534-A5F224A1D45D

P50

Q27677850-06829A70-23DB-4008-BA12-43CE6897648C

Q27677850-1C3C67AF-2F29-44E5-915B-7C1AFCB7EC3F

Q27677850-C37A1049-2387-4CD7-8761-469EA58F9B82

P577

Q27677850-DB24FC4F-A8FB-4649-B7EE-70D8C4A804DD

P5875

Q27677850-2FE302AD-717F-4CFB-BE81-4BEB61B4332E

P698

Q27677850-658CFDE6-45BB-4D5A-B8A5-8DD805D7312B

P3181

P356

P1433

Molecular Pharmacology

P1476

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

@en

P2093

Aleksandra Cvoro

http://www.w3.org/2001/XMLSchema#string

Amanda Bernardes

http://www.w3.org/2001/XMLSchema#string

Ana C Puhl

http://www.w3.org/2001/XMLSchema#string

Daniel M Saidemberg

http://www.w3.org/2001/XMLSchema#string

Jing Yuan

http://www.w3.org/2001/XMLSchema#string

Jéssica L O Campos

http://www.w3.org/2001/XMLSchema#string

Paul Webb

http://www.w3.org/2001/XMLSchema#string

Peter S Reinach

http://www.w3.org/2001/XMLSchema#string

Rodrigo L Silveira

http://www.w3.org/2001/XMLSchema#string

Stephen D Ayers

http://www.w3.org/2001/XMLSchema#string

P304

788-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

184001

http://www.w3.org/2001/XMLSchema#string

P356

10.1124/MOL.111.076216

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Igor Polikarpov

Mario Sergio Palma

P577

2012-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221888758

http://www.w3.org/2001/XMLSchema#string

P698

22391103

http://www.w3.org/2001/XMLSchema#string